Clinical Trials Directory

Trials / Unknown

UnknownNCT03766815

Effect of Branched-chain Amino Acid Supplementation on Muscle Damage

Effect of Branched-chain Amino Acid Supplementation on Muscle Damage in Recreational Athletes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
78 (estimated)
Sponsor
Western University, Canada · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Seventy-eight recreational athletes who never resistance trained will be randomly assigned into three groups of twenty-six. Branched-chain amino acid will be supplemented for 18days at 0, 200 or 400 mg/body weight(kg)/day in jelly. Participants will be asked to perform elbow flexions on the 12th day of supplementation. Maximum voluntary contractions will be measured before, during and after the supplementation period to compare the effects of different doses of branched-chain amino acid has on muscle damage markers.

Detailed description

Previous studies have not been able to show consistent effects due to various reasons. The major limitations are the lack of enough data on the amount and duration of branched-chain amino acid supplementation, and the level of muscle damage for branched-chain amino acid to be effective. Based on a recent meta-analysis, it has been suggested that to be effective, branched-chain amino acid should be supplemented more than 200mg/kg/day before a low-to-moderate intensity exercise bout. Therefore, this study is designed based on the above suggestions and to compare the effect of different doses of branched-chain amino acid on muscle damage markers in healthy recreational active individuals. Three treatment groups (n=26) will be randomly assigned to be supplemented with either 200mg BCAA/kg/day (BCAA200), 400mg BCAA/kg/day (BCAA400) or placebo (fiber supplement; PL). Supplements will be provided in jelly in a single blind fashion to be ingested 1hour after each of the three main daily meals for 18days. Anthropometric measurements (body weight, lean mass, height), body temperature, ultrasound (US), strength assessment (maximal voluntary contraction, MVC), resting metabolic rate (RMR), rate of perceived exertion (RPE), delayed onset of muscle soreness (DOMS) and blood samples (duplicates; myoglobin; BCAA) will be collected before, during and after the supplementation period at different time points (see appendix for the above tables). Repeated-bout effect (RBE) on both arms will be measured 7 days after the damage inducing session.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBCAA 200mg/kg/dayBCAA supplement based on 200mg/kg/day for 18 days.
DIETARY_SUPPLEMENTPlaceboFiber supplement jelly for 18 days.
DIETARY_SUPPLEMENTBCAA 400mg/kg/dayBCAA supplement based on 400mg/kg/day for 18 days.
BEHAVIORALMuscle damaging exerciseParticipants will be asked to perform muscle damaging elbow eccentric contraction exercise at 120% of 1RM for three sets of 15 repetitions with the dominant arm at maximal effort on a Biodex machine with a 3 minute rest period between each set.

Timeline

Start date
2019-10-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-12-06
Last updated
2019-10-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03766815. Inclusion in this directory is not an endorsement.